Showing 1 - 10 of 10,800
outbreak. Furthermore, it elaborates on patent-related policy options provided by the TRIPS Agreement, and WTO Members …COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and …
Persistent link: https://www.econbiz.de/10012303912
Persistent link: https://www.econbiz.de/10012433647
Persistent link: https://www.econbiz.de/10012433890
Persistent link: https://www.econbiz.de/10013167212
and unequal access will lead to an increase in international inequalities, leaving a large part of the world to have … not achieve their goal of democratizing access to vaccines. In this sense, the current TRIPS (Agreement on Trade …
Persistent link: https://www.econbiz.de/10012496070
Persistent link: https://www.econbiz.de/10011549498
support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …
Persistent link: https://www.econbiz.de/10013194325
The World Trade Organisation’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS … surveillance, tracking, diagnosis and treatment of COVID-19. A possible solution is a TRIPS waiver of the implementation …, application and enforcement for the prevention, containment or treatment of COVID-19. This comment addresses the ways that TRIPS …
Persistent link: https://www.econbiz.de/10014082091
Persistent link: https://www.econbiz.de/10014364285
Persistent link: https://www.econbiz.de/10013470005